ASEP Medical Holdings Company Description

ASEP Medical Holdings Inc., together with its subsidiaries, focuses on developing diagnostic and therapeutic solutions for the treatment of sepsis.

It offers peptide technology for therapeutic applications, including bacterial biofilm infections, anti-inflammatories, anti-infective immune-modulators, and vaccine adjuvants; diagnostic kits for predicting the onset of severe sepsis and organ failure; and coatings for medical devices.

The company was formerly known as Trenchant Life Sciences Investment Corp. and changed its name to ASEP Medical Holdings Inc. in November 2021.

ASEP Medical Holdings Inc. was incorporated in 2021 and is headquartered in Victoria, Canada.

ASEP Medical Holdings Inc.

Country	Canada
Founded	2021
Industry	Biotechnology
Sector	Healthcare
Employees	7
CEO	Robert E. Hancock

Contact Details

Address: 730 View Street Victoria, British Columbia V8W 3Y7 Canada
Phone	778 600 0509
Website	asepmedical.com

Stock Details

Ticker Symbol	ASEP
Exchange	Canadian Securities Exchange
Fiscal Year	January - December
Reporting Currency	CAD
ISIN Number	CA04368A1057
SIC Code	3841

Key Executives

Name	Position
Dr. Robert E. W. Hancock FRSC, OC, Ph.D.	Founder, Chief Executive Officer and Executive Chairman
Jacqueline M. Tucker F.C.A., FCPA	Chief Financial Officer
Timothy W. Murphy	Chief Operating Officer, Corporate Secretary and Director
Dr. Evan Haney	Chief Scientific Officer
Dr. Fadia Saad M.B.A., Ph.D.	Chief Business Development Officer